Epstein-Barr
Mesenchymal Stem Cells for the Treatment of EBV-Induced Chronic Fatigue Syndrome: A Pilot Study
EBV-specific adoptive T cell therapy was well tolerated. Clinical improvement
November 20, 2024
EBV-specific adoptive T cell therapy was well tolerated. Clinical improvement
It is now clear that EBV must be contained and
Article from Harvard on Stem Cells and Diabetes
UC David Study Shows Promise…This article reports on the 18-month
This article details a study on human bone marrow-derived mesenchymal
Study showed that stem cell group had a higher rate
Registration
required to read the full study
n recent advancements, stem cell therapy has been recognized as
From NCBI published in May 2024
Spring of 2024 research update from the MS Association of
As a chronic autoimmune inflammatory disorder, Rheumatoid Arthritis may be
This study published in PLOS ONE evaluates the safety and
People with lupus know there’s no cure for their condition.
Human leukocyte antigen-G (HLA-G) is a pivotal protein involved
Introduction: Cannabinoids such as ▵-9-THC and CBD can downregulate the
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by
This article explores the potential of mesenchymal stem cell therapy
This article explains the potential of stem cell therapies in
This article reviews recent clinical trials evaluating the safety and